Results 161 to 170 of about 110,931 (189)

Bevacizumab

Reactions Weekly, 2013
  +4 more sources

Bevacizumab

Reactions Weekly, 2019
openaire   +2 more sources

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

Annals of Oncology, 2023
C Lefeuvre-Plesse, A Leary, E Pujade-Lauraine   +2 more
exaly  

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

Cancer Treatment Reviews, 2020
Olivier Chinot, Robert L Coleman, Alan Sandler   +2 more
exaly  

Bevacizumab

Reactions Weekly, 2020
  +4 more sources

Bevacizumab

Reactions Weekly, 2021
openaire   +2 more sources

Bevacizumab

Reactions Weekly, 2023
openaire   +1 more source

Bevacizumab

Reactions Weekly, 2012
openaire   +2 more sources

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

European Journal of Cancer, 2023
Marianna Silletta, Angelo della Corte, Fabio Piscaglia   +2 more
exaly  

Bevacizumab

Reactions Weekly, 2022
openaire   +2 more sources